J3410 HCPCS Level II code: Injection, hydroxyzine hcl, up to 25 mg
J3410 is the HCPCS code for “Injection, hydroxyzine hcl, up to 25 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J3410Injection, hydroxyzine hcl, up to 25 mg
Short description: Hydroxyzine hcl injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J3410 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1982
Where J3410 sits
- 1J codesDrugs administered other than orally
- 2Active code J3410Injection, hydroxyzine hcl, up to 25 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J3410 mean?
J3410 is the HCPCS code for “Injection, hydroxyzine hcl, up to 25 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J3410?
CMS lists J3410’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J3410
All J codesJ3401Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 mlJ3402Injection, remestemcel-l-rknd, per therapeutic doseJ3403Revakinagene taroretcel-lwey, per implantJ3404Injection, zopapogene imadenovec-drba suspension, per therapeutic doseJ3405Injection, onasemnogene abeparvovec-brve, per treatmentJ3406Injection, omidubicel-onlv, per therapeutic doseJ3411Injection, thiamine hcl, 100 mgJ3415Injection, pyridoxine hcl, 100 mgJ3420Injection, vitamin b-12 cyanocobalamin, up to 1000 mcgJ3424Injection, hydroxocobalamin, intravenous, 25 mgJ3425Injection, hydroxocobalamin, intramuscular, 10 mcgJ3430Injection, phytonadione (vitamin k), per 1 mg